ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

VTGN Stock Ownership Breakdown

NASDAQ : VTGN

VistaGen Therapeutics, Inc.

$2.79

-0.12-4.12%

At Close 4:00 PM

57.94

B-ESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

VTGN Stock Outstanding Shares

Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.

ShortableYes

OptionableYes

Short Percent Of Outstanding Shares2.67

Short Percent Of Float4.01

Shares Outstanding28.86M

Shares Float20.22M

Shares Short744.39K

Short Ratio3.34

4.01%

Short % of Float

2.67%

Short % of Shares Outstanding

Market Insider VTGN

Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.

Major Holders Summary

0.26% Percentage of Shares held by All Insiders

52.64% Percentage of Shares held by All Institutions

52.78% Percentage of Float held by Institutions

Number of Institutions Holding Shares

Institutional Ownership

About 52.64% of VTGN shares are held by financial institutions. TCG CROSSOVER MANAGEMENT, LLC is the top corporate investor, holding 2.68M shares valued at $14.13M. A 9.11% stake in VistaGen Therapeutics, Inc. is owned by the company. TCG CROSSOVER MANAGEMENT, LLC owns 2.68M shares valued at $13.76M, which translates its holding of 9.11% of the stake in the company.

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Mar 31, 2024	TCG CROSSOVER MANAGEMENT, LLC	9.11%	2.68M	14.13M	0	0
Dec 31, 2023	TCG CROSSOVER MANAGEMENT, LLC	9.11%	2.68M	13.76M	2.68M	+100.00%

VTGN Insiders

Among the VTGN insiders holding of 0.26% of the stake in company, SHAH NIMISH P, , holds the largest shares of 20.64M. VENROCK HEALTHCARE CAPITAL PARTNERS II, L.P., 10 percent owner, is the second largest VTGN insider with ownership of 20.64M shares. COMMODORE CAPITAL LP, 10 percent owner, stands third with possession of 1.58M shares of that stake.

Insiders	Designation	Shares Held
SHAH NIMISH P		20.64M
VENROCK HEALTHCARE CAPITAL PARTNERS II, L.P.	10 percent owner	20.64M
COMMODORE CAPITAL LP	10 percent owner	1.58M
SINGH SHAWN	CHIEF EXECUTIVE OFFICER	626.23K
ADLER REID G.	CHIEF LEGAL OFFICER	334.63K
GIN JERRY B		100K
DOTSON JERROLD DUANE	VP, CFO AND SECRETARY	72.79K
SAXE JON S	director	50K
SNODGRASS H. RALPH	PRES./CHIEF SCIENTIFIC OFFICER	34.64K
CATO ALLEN EASLEY	10 percent owner	28.07K
JONES STEPHANIE	PRESIDENT	17.9K
CATO HOLDING CO	10 percent owner	0

Buying/Selling by Insiders

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Aug 07, 2023	COMMODORE CAPITAL LP	PURCHASE	23.15	775.76K	17.96M	1.58M
Aug 18, 2022	GIN JERRY B	PURCHASE	0.18	100K	17.87K	100K
Aug 17, 2022	SINGH SHAWN	PURCHASE	0.17	600K	103.2K	626.23K
Aug 17, 2022	ADLER REID G.	PURCHASE	0.17	300K	50.91K	334.63K
Jul 12, 2022	SHAH NIMISH P	SALE	0.89	60K	53.4K	20.64M
Jul 12, 2022	VENROCK HEALTHCARE CAPITAL PARTNERS II, L.P.	SALE	0.89	60K	53.4K	20.64M
Sep 07, 2021	DOTSON JERROLD DUANE	SALE	3.13	30K	93.75K	72.79K
Aug 17, 2021	SNODGRASS H. RALPH	PURCHASE	2.73	3.75K	10.24K	34.64K
Aug 21, 2020	SAXE JON S	PURCHASE	0.69	30K	20.7K	50K
Nov 20, 2019	SNODGRASS H. RALPH	PURCHASE	0.34	15K	5.1K	15K
Mar 14, 2019	SAXE JON S	PURCHASE	1.27	7.92K	10.09K	20K
Mar 13, 2019	SAXE JON S	PURCHASE	1.26	12.08K	15.2K	12.08K
May 31, 2017	GIN JERRY B	PURCHASE	4.00	25K	100K	25K
Dec 15, 2011	CATO HOLDING CO	PURCHASE	1.75	34.94K	61.15K	0
Dec 15, 2011	CATO ALLEN EASLEY	SALE	1.75	6.99K	12.23K	28.07K
May 09, 2011	JONES STEPHANIE	SALE	0.00	4.98M	-	17.9K

Frequently Asked Questions

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter